Browsing by Author "Kaplan Y.C."

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Thumbnail Image
    Article
    Citation - Scopus: 6
    Evaluation of Satisfaction With Over-The Weight Loss Supplements
    (2013) Kaplan M.D.; Kasnakoü?lu B.T.; Yigitbasi T.; Kaplan Y.C.
    majority of studies on satisfaction with medication examine satisfaction with a prescribed pharmaceutical agent, while exploration of satisfaction with over-The-counter drugs is limited. This study aims to examine satisfaction with non-prescribed weight loss supplements and the factors that may affect satisfaction levels, such as overall body satisfaction. The participants in this study consisted of a convenience sample of 119 subjects who have either used weight loss supplement or are still using it at the time of enrollment. Results indicate that perceived effectiveness of weight loss supplement is the ultimate predictor of global satisfaction. Overall assessment of weight loss supplement revealed low satisfaction levels with regard to effectiveness and global satisfaction, while satisfaction with side-effects and convenience were relatively high. Body dissatisfaction was found to be significantly negatively correlated to satisfaction with effectiveness, side-effects and global satisfaction with weight loss supplement. Moreover, subjects with higher body dissatisfaction have a higher expectancy from weight loss supplement. © The Author(s) 2013.
  • Thumbnail Image
    Review
    Citation - Scopus: 33
    Use of Phenytoin, Phenobarbital Carbamazepine, Levetiracetam Lamot-E Rigine and Valproate in Pregnancy and Breastfeeding: Risk of Major Malformations, Dose-Dependency, Monotherapy Vs Polytherapy, Pharmacokinetics and Clinical Implications
    (Bentham Science Publishers, 2021) Kaplan Y.C.; Demir O.
    It is challenging to balance the fetal risks associated with the use of antiepileptic drugs (AEDs) against maternal and fetal risks of seizure worsening, and therefore it is very important to define and distinguish the possible risks entailed by different AEDs. This paper aims to undertake a comprehensive review regarding the possible risks of four classical (phenytoin’ carbamazepine’ phenobarbital’ and valproate) and two newer (lamotrigine and levetiracetam) AEDs during pregnancy. The review focuses on major and organ-specific malformations’ dose-dependent risks’ mono vs polytherapy’ and clinical pharmacokinetics. A discussion regarding the safety of AED use during breastfeeding is also provided. © 2021 Bentham Science Publishers